Wave Life Sciences, Inc. (WVE)
NASDAQ: WVE · Real-Time Price · USD
3.590
-0.040 (-1.10%)
At close: Oct 30, 2026, 4:00 PM EDT
3.630
+0.040 (1.11%)
After-hours: Oct 30, 2026, 7:51 PM EDT
Wave Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 197.32 | 602.07 | 302.08 | 200.35 | 88.5 | 150.56 |
Cash & Short-Term Investments | 430.75 | 602.07 | 302.08 | 200.35 | 88.5 | 150.56 |
Cash Growth | 119.53% | 99.31% | 50.77% | 126.39% | -41.22% | -18.39% |
Receivables | 12 | 1.28 | 1.42 | 21.09 | - | - |
Prepaid Expenses | 11.56 | 8.4 | 9.54 | 9.91 | 7.93 | 6.58 |
Other Current Assets | 4.33 | 3.08 | 7.35 | 4.02 | 2.11 | 5.42 |
Total Current Assets | 458.63 | 614.81 | 320.39 | 235.37 | 98.54 | 162.56 |
Property, Plant & Equipment | 44.33 | 19.86 | 28 | 35.72 | 44.13 | 40.64 |
Other Long-Term Assets | 4.71 | 3.82 | 3.82 | 3.86 | 3.72 | 3.8 |
Total Assets | 507.93 | 638.5 | 352.21 | 274.95 | 146.39 | 207.01 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 19.3 | 15.7 | 16.26 | 12.84 | 16.92 | 7.28 |
Accrued Expenses | 21.98 | 26.56 | 21.08 | 16.83 | 17.55 | 14.86 |
Current Portion of Leases | 4.38 | 8.36 | 7.64 | 6.71 | 5.5 | 4.96 |
Current Unearned Revenue | 9.11 | 44.44 | 65.97 | 150.06 | 31.56 | 37.1 |
Total Current Liabilities | 54.76 | 95.07 | 110.95 | 186.44 | 71.52 | 64.2 |
Long-Term Leases | 38.9 | 9.41 | 17.77 | 25.4 | 32.12 | 24.96 |
Long-Term Unearned Revenue | 12.34 | 7.8 | 6.1 | 15.6 | 79.77 | 77.48 |
Other Long-Term Liabilities | - | - | - | - | 0.19 | - |
Total Liabilities | 105.99 | 112.27 | 134.82 | 227.45 | 183.6 | 166.64 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.2 | 1,616 | 1,175 | 935.37 | 802.83 | 749.85 |
Additional Paid-In Capital | 1,886 | 228.37 | 156.45 | 129.24 | 119.44 | 87.98 |
Retained Earnings | -1,484 | -1,326 | -1,122 | -1,025 | -967.34 | -805.51 |
Comprehensive Income & Other | -0.57 | -0.25 | -0.26 | -0.12 | -0.03 | 0.18 |
Total Common Equity | 401.94 | 518.36 | 209.52 | 39.63 | -45.09 | 32.5 |
Shareholders' Equity | 401.94 | 526.23 | 217.39 | 47.5 | -37.22 | 40.37 |
Total Liabilities & Equity | 507.93 | 638.5 | 352.21 | 274.95 | 146.39 | 207.01 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 43.27 | 17.77 | 25.4 | 32.12 | 37.61 | 29.92 |
Net Cash (Debt) | 387.74 | 584.3 | 276.67 | 168.23 | 50.88 | 120.65 |
Net Cash Growth | 119.75% | 111.19% | 64.46% | 230.63% | -57.83% | -22.26% |
Net Cash Per Share | 1.97 | 3.46 | 2.00 | 1.59 | 0.65 | 2.33 |
Filing Date Shares Outstanding | 197.23 | 188.25 | 153.49 | 122.28 | 98.1 | 60.84 |
Total Common Shares Outstanding | 197.21 | 187.66 | 153.04 | 119.16 | 86.92 | 59.84 |
Working Capital | 403.87 | 519.75 | 209.44 | 48.93 | 27.02 | 98.36 |
Book Value Per Share | 2.04 | 2.76 | 1.37 | 0.33 | -0.52 | 0.54 |
Tangible Book Value | 401.94 | 518.36 | 209.52 | 39.63 | -45.09 | 32.5 |
Tangible Book Value Per Share | 2.04 | 2.76 | 1.37 | 0.33 | -0.52 | 0.54 |
Machinery | - | 26.37 | 26.19 | 26.07 | 25.51 | 25.66 |
Construction In Progress | - | 0.6 | 0.35 | 0.29 | 0.32 | 0.03 |
Leasehold Improvements | - | 28.94 | 28.89 | 28.53 | 28.41 | 27.99 |